MRI signs of CNS demyelinating diseases

被引:9
|
作者
Etemadifar, Masoud [1 ]
Ashourizadeh, Helia [2 ]
Nouri, Hosein [3 ,4 ]
Kargaran, Parisa K. [5 ]
Salari, Mehri [6 ]
Rayani, Milad [3 ]
Aghababaee, Ali [3 ]
Abhari, Amir Parsa [3 ,4 ]
机构
[1] Isfahan Univ Med Sci, Dept Neurosurg, Esfahan, Iran
[2] Shahid Beheshti Univ Med Sci, Funct Neurosurg Res Ctr, Shohada Tajrish Neurosurg Ctr Excellence, Tehran, Iran
[3] Isfahan Univ Med Sci, Alzahra Res Inst, Esfahan, Iran
[4] Universal Sci Educ & Res Network USERN, Network Immun Infect Malignancy & Autoimmun NIIMA, Esfahan, Iran
[5] Mayo Clin, Ctr Regenerat Med, Dept Cardiovasc Med, Rochester, MN USA
[6] Shahid Beheshti Univ Med Sci, Dept Neurol Dis, Tehran, Iran
关键词
Magnetic Resonance Imaging; Demyelinating diseases; Multiple Sclerosis; Neuromyelitis Optica Spectrum Disorder;
D O I
10.1016/j.msard.2020.102665
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The differential diagnosis of the central nervous system (CNS) demyelinating diseases can be greatly facilitated by visualization and appreciation of pathognomonic radiological signs, visualized on magnetic resonance imaging (MRI) sequences. Given the distinct therapeutic approaches for each of these diseases, a decisive and reliable diagnosis in patients presenting with demyelination-associated symptoms is of crucial value. Multiple sclerosis (MS) and neuromyelitis optica spectrum disorder (NMOSD) are major examples of such conditions, each possessing a number of MRI signs, closely associated with the disorder. This pictorial review aims to describe seventeen pathognomonic MRI signs associated with several CNS demyelinating disorders including MS, NMOSD, myelin oligodendrocyte glycopmtein-associated disease, BalO's concentric sclerosis, metachromatic leukodystrophy, progressive multifocal leukoencephalopathy, and neurosarcoidosis.
引用
收藏
页数:7
相关论文
共 50 条
  • [21] Anterior optic pathway pathology in CNS demyelinating diseases
    Pisa, Marco
    Pansieri, Jonathan
    Yee, Sydney
    Ruiz, Jennifer
    Leite, Isabel M.
    Palace, Jacqueline
    Comi, Giancarlo
    Esiri, Margaret M.
    Leocani, Letizia
    DeLuca, Gabriele C.
    BRAIN, 2022, 145 (12) : 4308 - 4319
  • [22] Occurrence of CNS demyelinating diseases in Myasthenia Gravis patients
    Gotkine, M
    Fellig, Y
    Abramsky, O
    NEUROLOGY, 2006, 66 (05) : A226 - A226
  • [23] MRI CHARACTERISTICS OF CNS DEMYELINATING DISEASE IN ETHNIC INDIAN PATIENTS
    Hua, Le H.
    Lee, Jong-Mi
    Dorfman, Les
    Dunn, Jeffrey
    MULTIPLE SCLEROSIS JOURNAL, 2014, 20 (07) : 920 - 920
  • [24] Antibody biomarkers in CNS demyelinating diseases - a long and winding road
    Berger, T.
    Reindl, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2015, 22 (08) : 1162 - 1168
  • [25] Multiple sclerosis and the spectrum of CNS inflammatory demyelinating diseases - Preface
    Lucchinetti, Claudia F.
    SEMINARS IN NEUROLOGY, 2008, 28 (01) : 3 - 6
  • [26] Morphological changes of the retina and visual functions in demyelinating diseases of the cns
    Valis, M.
    Kremlacek, J. A. N.
    Pavelek, Z.
    Lehka, V.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2015, 357 : E252 - E252
  • [27] Morphological Changes of The Retina and Visual Functions in Demyelinating Diseases of The CNS
    Valis, M.
    Kremlacek, J.
    Pavelek, Z.
    Lehka, V.
    MULTIPLE SCLEROSIS JOURNAL, 2015, 21 (06) : 829 - 830
  • [28] Clinical use of CSF neopterin levels in CNS demyelinating diseases
    Miyaue, Noriyuki
    Hosokawa, Yuko
    Yamanishi, Yuki
    Tada, Satoshi
    Ando, Rina
    Nagai, Masahiro
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2022, 441
  • [29] Low-field portable brain MRI in CNS demyelinating disease
    Mateen, Farrah J.
    Cooley, Clarissa Zimmerman
    Stockmann, Jason P.
    Rice, Dylan R.
    Vogel, Andre C.
    Wald, Lawrence L.
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 51
  • [30] COVID-19 and the risk of CNS demyelinating diseases: a systematic review
    Lotan, I.
    Nishiyama, S.
    Manzano, G. S.
    Lydston, M.
    Levy, M.
    MULTIPLE SCLEROSIS JOURNAL, 2022, 28 (3_SUPPL) : 934 - 935